Photocatalytic Degradation Mechanism of the Pharmaceutical Agent Salbutamol Using the Mn-Doped TiO Nanoparticles Under Visible Light Irradiation.

In the present work, the photocatalytic degradation of salbutamol [2-(-butylamino)-1-(4-hydroxyl-3-hydroxymethylphenyl)ethanol] under visible irradiation using Mn-doped TiO is investigated. The Mn-doped TiO nanoparticles were synthesized by the sol-gel method with ratios of 0.1, 0.2, and 0.3%. Significant characteristics, including the rutile/anatase phases ratio, specific surface area, and band gap energy, were due to the amount of Mn doping; the narrowest band gap energy of 2.80 eV was observed in 0.2% Mn-doped TiO with specific surface areas of 89.36 m/g and 10.87/89.13 of rutile/anatase phases. The investigation involved salbutamol photocatalytic degradation, a kinetic study, and the identification of intermediate compounds. The results indicated that 0.2% Mn-doped TiO obtained the best salbutamol removal of 95% under an irradiation time of 180 min. Salbutamol slowly degraded to the intermediate compounds in the first 60 min ( = 0.0088 1/min), and these intermediate compounds were dramatically mineralized to small hydrocarbon fragments and carbon dioxide in the later irradiation times ( = 0.0179 1/min). According to the high-performance liquid chromatography-mass spectrometry (HPLC-MS) results, possible degradation pathways of salbutamol were proposed: 2-(-butylamino)-1-(3,4-dihydroxyphenyl)ethanone, 2-(-butylamino)-ethanol, and 2-(-butylamino)-1-(4-hydroxyl-3-hydroxymethylphenyl)ethanone were initially formed and then transformed to 2-(methylamino)-1-(3,4-dihydroxyphenyl)ethanone, 2-(-butylamino)-acetic acid, hydroquinone, and 1-(4-hydroxylphenyl)ethanol, respectively. The mineralization of all intermediate compounds was verified by 90% chemical oxygen demand (COD) reduction, and the effluent contained a relatively low COD concentration of 7.8 mg/L.